EVEREST ORGANICS
Back to Balance Sheet
|
EVEREST ORGANICS Last 5 Year Net Current Assets History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Net Current Assets (Including Current Investments) | ₹7.98 Cr | ₹-11 Cr | ₹-5.10 Cr | ₹5.32 Cr | ₹12 Cr |
What is the latest Net Current Assets ratio of EVEREST ORGANICS ?
| Year | Net Current Assets |
|---|---|
| Mar2025 | ₹7.98 Cr |
| Mar2024 | ₹-11 Cr |
| Mar2023 | ₹-5.10 Cr |
| Mar2022 | ₹5.32 Cr |
| Mar2021 | ₹12 Cr |
How is Net Current Assets of EVEREST ORGANICS Trending?
| Years | Net Current Assets | % Change | |
|---|---|---|---|
| Mar2025 | ₹7.98 Cr | Positive | |
| Mar2024 | ₹-11 Cr | Negative | |
| Mar2023 | ₹-5.10 Cr | Negative | |
| Mar2022 | ₹5.32 Cr | -55.29 | |
| Mar2021 | ₹12 Cr | - | |
Compare Net Current Assets of peers of EVEREST ORGANICS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| EVEREST ORGANICS | ₹329.8 Cr | 14% | 21.5% | -12.8% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹461,644.0 Cr | 1.2% | 8.3% | 15.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹184,053.0 Cr | -0.2% | 3% | -0.8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹167,464.0 Cr | 1.7% | 9.9% | 46.8% | Stock Analytics | |
| CIPLA | ₹115,263.0 Cr | -2.2% | 4.5% | -4.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹103,049.0 Cr | -9% | -2.1% | -1.8% | Stock Analytics | |
EVEREST ORGANICS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| EVEREST ORGANICS | 14% |
21.5% |
-12.8% |
| SENSEX | -0.9% |
4.9% |
-6.8% |
You may also like the below Video Courses